Malnutrition in childhood lymphoblastic leukemia:: A predictor of early mortality during the induction-to-remission phase of the treatment

被引:41
|
作者
Mejía-Aranguré, JM
Fajardo-Gutiérrez, A
Reyes-Ruíz, NI
Bernáldez-Ríos, R
Mejía-Domínguez, AM
Navarrete-Navarro, S
Martínez-García, MD
机构
[1] Ctr Med Nacl Siglo XXI, Hosp Pediat, Unidad Invest Med Epidemiol Clin, Mexico City 06725, DF, Mexico
[2] Ctr Med Nacl Siglo XXI, Hosp Pediat, Hematol Serv, Mexico City 06725, DF, Mexico
[3] Ctr Med Nacl Siglo XXI, Hosp Pediat, Unidad Invest Med Epidemiol Hosp, Mexico City 06725, DF, Mexico
[4] Secretaria Salud Mexico, Hosp Infantil Mexico Fed Gomez, Dept Oncol, Mexico City, DF, Mexico
[5] Secretaria Salud Mexico, Hosp Infantil Mexico Fed Gomez, Serv Alergol, Mexico City, DF, Mexico
关键词
leukemia; lymphoblastic; acute; nutritional status; child nutrition; chemotherapy;
D O I
10.1016/S0188-0128(98)00026-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Previous reports have shown that undernourished children with acute lymphoblastic leukemia (ALL) have a poorer long-term survival as compared with children with normal nourishment status, It has been shown that both the relapse and mortality rates of undernourished children with ALL are higher during the continuation phase of the chemotherapy and are apparently related to a poor tolerance of ablative chemotherapy. No previous articles have analyzed the early mortality rate of these patients, Methods. We carried out a case-control study, and have studied the effect of severe malnutrition on the mortality of 17 children with ALL during the initial induction-to-remission phase of the treatment. These 17 cases were compared with 76 controls who had survived at least the phases of induction and consolidation. Results. It was found that the chance of dying during the initial phase of the treatment was 2.6 times higher (confidence interval 95%: 0.55-11.89) in undernourished children with ALL than in those children with normal nourishment status. The risk of death increased with the severity of undernourishment (p = 0.04). Conclusions. These data confirm the prognostic value of malnutrition in children with ALL and suggest that undernourishment may also influence early mortality during the induction-to-remission phase of the treatment, (C) 1999 IMSS. Published by Elsevier Science Inc.
引用
收藏
页码:150 / 153
页数:4
相关论文
共 50 条
  • [41] CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia
    Das, Nupur
    Malhotra, Ankit
    Gupta, Ritu
    Rai, Sandeep
    Gupta, Sanjeev K.
    Sahoo, Ranjeet K.
    Gogia, Ajay
    Bakshi, Sameer
    Kumar, Lalit
    Singh, Saroj
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S197 - S197
  • [42] PREVALENCE AND RISK FACTORS FOR MALNUTRITION DURING PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA INDUCTION THERAPY
    Hill, Rachel
    Hamby, Tyler
    Boren, Charles
    Ali, Mir
    Johnson, Danielle
    Bowman, W. Paul
    Ray, Anish
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [43] T Cell Subsets During Early Life and Their Implication in the Treatment of Childhood Acute Lymphoblastic Leukemia
    Saghafian-Hedengren, Shanie
    Sverremark-Ekstrom, Eva
    Nilsson, Anna
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [44] Invasive colonic mucormycosis in early induction therapy of childhood acute lymphoblastic leukemia
    Sellappan B.
    Bakhshi S.
    Safaya R.
    Gupta A.K.
    Arya L.S.
    The Indian Journal of Pediatrics, 2005, 72 (1) : 77 - 79
  • [45] Isolated ocular relapse in childhood acute lymphoblastic leukemia during continuing complete remission
    LoCurto, M
    DAngelo, P
    Jankovic, M
    Fugardi, MG
    Ziino, O
    Casale, F
    HAEMATOLOGICA, 1996, 81 (01) : 47 - 50
  • [46] Apoptotic cell identification: An in-vivo study during induction treatment of childhood acute lymphoblastic leukemia
    Widjajanto, Pudjo H.
    Veerman, A. J. P.
    Sutaryo
    PAEDIATRICA INDONESIANA, 2006, 46 (9-10) : 195 - 198
  • [47] Neuropathic Pain During Treatment for Childhood Acute Lymphoblastic Leukemia
    Anghelescu, Doralina L.
    Faughnan, Lane G.
    Jeha, Sima
    Relling, Mary V.
    Hinds, Pamela S.
    Sandlund, John T.
    Cheng, Cheng
    Pei, Deqing
    Hankins, Gisele
    Pauley, Jennifer L.
    Pui, Ching-Hon
    PEDIATRIC BLOOD & CANCER, 2011, 57 (07) : 1147 - 1153
  • [48] WHICH TREATMENT FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN 2ND REMISSION
    BUTTURINI, A
    RIVERA, GK
    BORTIN, MM
    GALE, RP
    LANCET, 1987, 1 (8530): : 429 - 432
  • [49] INCIDENCE OF INFECTIOUS COMPLICATIONS DURING INDUCTION-PHASE OF TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITH BFM LIKE REGIMEN
    BRICHON, P
    BERTRAND, Y
    PARIS, A
    BARBE, G
    COCHAT, N
    SOUILLET, G
    PHILIPPE, N
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 404 - 404
  • [50] Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia
    Thyss, A
    Suciu, S
    Bertrand, Y
    Mazingue, F
    Robert, A
    Vilmer, E
    Mechinaud, F
    Benoit, Y
    Brock, P
    Ferster, A
    Lutz, P
    Boutard, P
    Marguerite, G
    Plouvier, E
    Michel, G
    Plantaz, D
    Munzer, M
    Rialland, X
    Chantraine, JM
    Norton, L
    Solbu, G
    Philippe, N
    Otten, J
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1824 - 1830